ArticlePreventing chronic disease2018
Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings.
Article in Preventing chronic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 208 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
HSII PCORI/OSF Hypertension (HTN) Care Management (PHCM) With Remote Patient Monitoring Support
Who cites it
208 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- Planning, implementation, evaluation, and sustainment of digital health interventions for adolescent substance use prevention: a systematic review of influencing factors based on the RE-AIM framework.Health education research · 2025Pooled it
- How to Best Develop and Deliver Generic Long-Term Condition Rehabilitation Programmes in Rural Settings: An Integrative Review.Frontiers in rehabilitation sciences · 2022Pooled it
- Training in Ultrasound to Determine Gestational Age in Low- and Middle- Income Countries: A Systematic Review.Frontiers in global women's health · 2022Pooled it
- Applying the RE-AIM implementation framework to evaluate fall prevention interventions in community dwelling adults with cognitive impairment: a review and secondary analysis.BMC geriatrics · 2021Pooled it
- Evaluating the Application of the RE-AIM Planning and Evaluation Framework: An Updated Systematic Review and Exploration of Pragmatic Application.Frontiers in public health · 2021Pooled it
- A systematic review of the implementation of obesity prevention interventions in early childcare and education settings using the RE-AIM framework.Translational behavioral medicine · 2020Pooled it
- Rural physical activity interventions in the United States: a systematic review and RE-AIM evaluation.The international journal of behavioral nutrition and physical activity · 2019Pooled it
- Health professional-delivered obesity prevention interventions during the first 1,000 days: A systematic review of external validity reporting.HRB open research · 2019Pooled it
- Trial
- Experiences with implementing advance care planning (ACP-GP) in Belgian general practice in the context of a cluster RCT: a process evaluation using the RE-AIM framework.BMC primary care · 2024Trial
- Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trial.BMC public health · 2024Trial
- The Impact of Video-Based Microinterventions on Attitudes Toward Mental Health and Help Seeking in Youth: Web-Based Randomized Controlled Trial.Journal of medical Internet research · 2024Trial
- Artificial intelligence predictive analytics in heart failure: results of the pilot phase of a pragmatic randomized clinical trial.Journal of the American Medical Informatics Association : JAMIA · 2024Trial
- Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial.Addiction science & clinical practice · 2023Trial
- Trial
- Trial
- Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center.PloS one · 2022Trial
- Process evaluation of an implementation study in dementia care (EIT-4-BPSD): stakeholder perspectives.BMC health services research · 2021Trial
- Re-thinking Physical Activity Programs for Older Brazilians and the Role of Public Health Centers: A Randomized Controlled Trial Using the RE-AIM Model.Frontiers in public health · 2020Trial
- Pilot randomized controlled trial of a peer coach-led behavioral and educational intervention to enhance quality of life in patients living with hypersensitivity pneumonitis: Protocol for the RISE-HP study.Contemporary clinical trials communications · 2026Article
148 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The RE-AIM (Reach Effectiveness Adoption Implementation Maintenance) planning and evaluation framework has been applied broadly, but users often have difficulty in applying the model because of data collection needs across multiple domains and sources. Questions in the more common "who, what, where, how, when, and why" format may be an effective guide to ensure that individual participants, organization staff, and the perspectives of the setting are considered in planning and evaluation. Such a format can also help users in typical community and clinical settings to identify which outcomes are most valued and to focus limited measurement resources. Translations of RE-AIM that are easy to understand and apply are needed for application in real-world community and clinical settings where research and evaluation resources are limited. The purpose of this article is to provide simplified, pragmatic, user-centered and stakeholder-centered recommendations to increase the use of RE-AIM in community and clinical settings and in translational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.